These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques. Hubbard WJ; Moore JK; Contreras JL; Smyth CA; Chen ZW; Lobashevsky AL; Nagata K; Neville DM; Thomas JM Hum Immunol; 2001 May; 62(5):479-87. PubMed ID: 11334671 [TBL] [Abstract][Full Text] [Related]
10. Treatment with immunotoxin. Knechtle SJ Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071 [TBL] [Abstract][Full Text] [Related]
11. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Boskovic S; Kawai T; Smith RN; Wee SL; Nadazdin O; Koyama I; Saidman S; Cardarelli F; Elias N; Sykes M; Strom T; Colvin RB; Sachs DH; Cosimi AB Transplantation; 2006 Sep; 82(6):819-25. PubMed ID: 17006330 [TBL] [Abstract][Full Text] [Related]
12. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. Fechner JH; Vargo DJ; Geissler EK; Wang J; Neville DM; Knechtle SJ Transplant Proc; 1997; 29(1-2):1158. PubMed ID: 9123249 [No Abstract] [Full Text] [Related]
14. Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients. Contreras JL; Eckhoff DE; Cartner S; Frenette L; Thomas FT; Robbin ML; Neville DM; Thomas JM Transplantation; 1999 Jul; 68(2):215-9. PubMed ID: 10440390 [TBL] [Abstract][Full Text] [Related]
15. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys. Jonker M; Ringers J; Ossevoort MA; Slingerland W; van den Hout Y; Haanstra K; Wubben J; Kuhn E; Friend P; Calne R Transplantation; 2002 Mar; 73(6):874-80. PubMed ID: 11923686 [TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses. Waaga AM; Ulrichs K; Krzymanski M; Treumer J; Hansmann ML; Rommel T; Müller-Ruchholtz W Transplant Proc; 1990 Aug; 22(4):1613-4. PubMed ID: 2389421 [No Abstract] [Full Text] [Related]
17. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393 [TBL] [Abstract][Full Text] [Related]
18. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021 [TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
20. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Armstrong N; Buckley P; Oberley T; Fechner J; Dong Y; Hong X; Kirk A; Neville D; Knechtle S Transplantation; 1998 Jul; 66(1):5-13. PubMed ID: 9679815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]